Details for New Drug Application (NDA): 017675
✉ Email this page to a colleague
The generic ingredient in TENATHAN is bethanidine sulfate. Additional details are available on the bethanidine sulfate profile page.
Summary for 017675
Tradename: | TENATHAN |
Applicant: | Robins Ah |
Ingredient: | bethanidine sulfate |
Patents: | 0 |
Medical Subject Heading (MeSH) Categories for 017675
Profile for product number 001
Active Rx/OTC/Discontinued: | DISCN | Dosage: | TABLET;ORAL | Strength | 10MG | ||||
Approval Date: | Approved Prior to Jan 1, 1982 | TE: | RLD: | No |
Profile for product number 002
Active Rx/OTC/Discontinued: | DISCN | Dosage: | TABLET;ORAL | Strength | 25MG | ||||
Approval Date: | Approved Prior to Jan 1, 1982 | TE: | RLD: | No |
Expired US Patents for NDA 017675
Applicant | Tradename | Generic Name | Dosage | NDA | Approval Date | Patent No. | Patent Expiration |
---|---|---|---|---|---|---|---|
Robins Ah | TENATHAN | bethanidine sulfate | TABLET;ORAL | 017675-001 | Approved Prior to Jan 1, 1982 | ⤷ Subscribe | ⤷ Subscribe |
Robins Ah | TENATHAN | bethanidine sulfate | TABLET;ORAL | 017675-002 | Approved Prior to Jan 1, 1982 | ⤷ Subscribe | ⤷ Subscribe |
>Applicant | >Tradename | >Generic Name | >Dosage | >NDA | >Approval Date | >Patent No. | >Patent Expiration |
Complete Access Available with Subscription